XML 22 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 64,928 $ 59,632
Accounts receivable, net 31,625 32,286
Inventory 49,212 46,845
Prepaid expenses and other current assets 7,609 6,136
Total current assets 153,374 144,899
Property and equipment, net 60,262 61,561
Field equipment, net 24,264 22,309
Deferred cost of revenues, net 31,410 33,165
Intangible assets, net 7,660 9,688
Goodwill 42,748 42,648
Other assets 5,911 2,937
Total assets 325,629 317,207
Current liabilities:    
Accounts payable 14,785 14,177
Accrued expenses 27,985 30,985
Current portion of long-term debt 101 328
Other current liabilities 4,559 3,770
Total current liabilities 47,430 49,260
Deferred revenues 46,874 49,001
Long-term debt 520 1,305
Other long-term liabilities 17,824 15,568
Total liabilities 112,648 115,134
Commitments and contingencies (Note 10)
Noncontrolling interests subject to put provisions (165) 50
Stockholders’ equity:    
Undesignated preferred stock: par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding as of December 31, 2017 and 2016 0 0
Common stock: par value $0.001 per share, 100,000,000 shares authorized; 67,341,819 and 65,883,026 shares issued as of December 31, 2017 and 2016, respectively 67 65
Additional paid-in capital 657,640 631,219
Accumulated deficit (421,593) (407,601)
Accumulated other comprehensive loss (3,673) (6,101)
Treasury stock, at cost: 1,046,870 and 936,360 shares as of December 31, 2017 and 2016, respectively (19,283) (16,184)
Total NxStage Medical, Inc. stockholders’ equity 213,158 201,398
Noncontrolling interests not subject to put provisions (12) 625
Total stockholders’ equity 213,146 202,023
Total liabilities and stockholders’ equity $ 325,629 $ 317,207